Omipalisib
Omipalisib (GSK2126458) is a potent, small-molecule PI3K inhibitor with a pyridylsulfonamide structure. It is widely used in oncology research to study PI3K pathway signaling in both cellular and animal models of cancer.
Product Specifications
CAS Number
1086062-66-9
Product Name Alternative
GSK2126458, GSK-2126458, GSK 2126458, GSK 458, GSK458, GSK-458, Mammalian target of Rapamycin, inhibit, mTORC1, mTOR, Inhibitor, Omipalisib, Autophagy, Phosphoinositide 3-kinase, PI3K, p110α, p110δ, p110β, p110γ
Field of Research
Cell Biology, Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.96 mM) ; DMSO:50 mg/mL (98.91 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COc1ncc (cc1NS (=O) (=O) c1ccc (F) cc1F) -c1ccc2nccc (-c3ccnnc3) c2c1
Molecular Formula
C25H17F2N5O3S
Molecular Weight
505.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV731448 1.0 µg DNA
LINC00358 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
B0006 00500 500 mL
Buffer Solution pH 1.68 ± 0.01 @ 25°c Traceable to NIST
Sign In for Pricing
View Details MBS026313 Inquire
Goat Atrial Natriuretic Peptide-Converting Enzyme ELISA Kit
Sign In for Pricing
View Details